Norchi Terrence W 4
4 · Arch Therapeutics, Inc. · Filed Dec 23, 2019
Insider Transaction Report
Form 4
Norchi Terrence W
DirectorPres, CEO, Sec, and Treas10% Owner
Transactions
- Award
Stock Option (right to buy)
2019-12-20+1,000,000→ 1,000,000 totalExercise: $0.23Exp: 2029-12-19→ Common Stock (1,000,000 underlying)
Footnotes (1)
- [F1]The Shares subject to the Option, 25% shall vest immediately and 1/36 of the remaining shares shall vest on each of the next thirty-six (36) monthly anniversaries of the commencement date. Such shares will remain exercisable for 365 days after written notice of termination by either party. In the event of a Change of Control (as such term is defined in the Plan) all Options subject to this grant will immediately vest.